Stock Events

Stock Events

Cardiol Therapeutics (CT9.F) Q4 2024 Earnings

14NovConfirmed

Q2 2024

Q3 2024

Q4 2024

-0.13

-0.11

-0.09

-0.07

Details

Expected EPS

-0.089441177120451

Actual EPS

-0.12633232014

Surprise EPS

-0.04

Surprise Percent

+41.25%

Description

Cardiol Therapeutics (CT9.F) has reported earnings of -0.12633232014 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.